{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T21:26:10Z","timestamp":1773869170695,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":56,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023181","name":"Agencja Bada\u0144 Medycznych","doi-asserted-by":"publisher","award":["BPN\/WAL\/2023\/1\/00061"],"award-info":[{"award-number":["BPN\/WAL\/2023\/1\/00061"]}],"id":[{"id":"10.13039\/501100023181","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014434","name":"Narodowa Agencja Wymiany Akademickiej","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001870","name":"Fundacja na rzecz Nauki Polskiej","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001870","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["phiro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physics and Imaging in Radiation Oncology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.phro.2025.100829","type":"journal-article","created":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T22:40:34Z","timestamp":1756593634000},"page":"100829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The prognostic value of baseline 18FDG \u2013 Positron Emission Tomography \u2013 Computed Tomography in cervical cancer patients treated with definitive chemoradiotherapy \u2013 External multicentre validation model"],"prefix":"10.1016","volume":"35","author":[{"given":"Emilia","family":"Staniewska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Stankiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Burchardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"Grudzien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Raczek-Zwierzycka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justyna","family":"Rembak-Szynkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matylda","family":"Sobczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"d\u2019Amico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damian","family":"Borys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izabela","family":"Gorczewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamil","family":"Krysiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Rydzinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafal","family":"Stando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mateusz","family":"Spalek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzanna","family":"Nowicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafal","family":"Tarnawski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Miszczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phro.2025.100829_b0005","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.phro.2025.100829_b0010","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer. Version 3.2024. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cervical.pdf (2024)."},{"key":"10.1016\/j.phro.2025.100829_b0015","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer. NCCN Evidence Blocks. Version 3.2024. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cervical_blocks.pdf (2024)."},{"issue":"22\u201336","key":"10.1016\/j.phro.2025.100829_b0020","first-page":"1","article-title":"Cancer of the cervix uteri","volume":"143","author":"Bhatla","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.phro.2025.100829_b0025","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-020-05112-2","article-title":"EANM\/SNMMI practice guideline for [18F]FDG PET\/CT external beam radiotherapy treatment planning in uterine cervical cancer v1.0","author":"Adam","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.phro.2025.100829_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/metabo11120809","article-title":"Prognostic value of pretherapeutic primary tumour MTV from [18F]FDG PET in radically treated cervical cancer patients","volume":"11","author":"Cegla","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.phro.2025.100829_b0035","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s13139-010-0062-8","article-title":"The prognostic value of the metabolic tumor volume in FIGO stage IA to IIB cervical cancer for tumor recurrence: measured by F-18 FDG PET\/CT","volume":"45","author":"Kim","year":"2011","journal-title":"Nucl Med Mol Imaging"},{"key":"10.1016\/j.phro.2025.100829_b0040","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/IGC.0b013e318260a905","article-title":"Prognostic significance of volume-based metabolic parameters in uterine cervical cancer determined using F-fluorodeoxyglucose positron emission tomography","volume":"22","author":"Yoo","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.phro.2025.100829_b0045","first-page":"1","article-title":"The role of the metabolic parameters of 18F-FDG PET\/CT in patients with locally advanced cervical cancer","volume":"11","author":"Wang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.phro.2025.100829_b0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13014-016-0614-x","article-title":"[18F]FDG-PET\/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy","volume":"11","author":"Herrera","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.phro.2025.100829_b0055","doi-asserted-by":"crossref","first-page":"e2992","DOI":"10.1097\/MD.0000000000002992","article-title":"Prognostic value of the sum of metabolic tumor volume of primary tumor and lymph nodes using 18F-FDG PET\/CT in patients with cervical cancer","volume":"95","author":"Hong","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.phro.2025.100829_b0060","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s00259-018-4219-5","article-title":"Chemoradiotherapy for locally advanced cervix cancer without aortic lymph node involvement: can we consider metabolic parameters of pretherapeutic FDG-PET\/CT for treatment tailoring?","volume":"46","author":"Voglimacci","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.phro.2025.100829_b0065","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00259-007-0612-1","article-title":"Standardized uptake value in para-aortic lymph nodes is a significant prognostic factor in patients with primary advanced squamous cervical cancer","volume":"35","author":"Yen","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.phro.2025.100829_b0070","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s00259-020-05136-8","article-title":"Optimal method for metabolic tumour volume assessment of cervical cancers with inter-observer agreement on [18F]-fluoro-deoxy-glucose positron emission tomography with computed tomography","volume":"48","author":"Arshad","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.phro.2025.100829_b0075","unstructured":"American Joint Committee on Cancer. Cervix Uteri. In: AJCC cancer staging manual. 8th ed. Springer 2017; 649\u2013659."},{"key":"10.1016\/j.phro.2025.100829_b0080","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.phro.2025.100829_b0085","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"10.1016\/j.phro.2025.100829_b0090","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","article-title":"A new look at the statistical model identification","volume":"19","author":"Akaike","year":"1974","journal-title":"IEEE Trans Autom Control"},{"key":"10.1016\/j.phro.2025.100829_b0095","article-title":"Prognostic value of pretreatment FDG PET\/CT in uterine cervical cancer according to two major histologic types: squamous cell carcinoma and adenocarcinoma","volume":"11","author":"Otani","year":"2023","journal-title":"Asia Ocean J Nucl Med Biol"},{"key":"10.1016\/j.phro.2025.100829_b0100","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/0284186X.2023.2181100","article-title":"Metabolic parameters of [18 F]FDG PET-CT before and after radiotherapy may predict survival and recurrence in cervical cancer","volume":"62","author":"Markus","year":"2023","journal-title":"Acta Oncol"},{"key":"10.1016\/j.phro.2025.100829_b0105","doi-asserted-by":"crossref","first-page":"e3017","DOI":"10.1097\/MD.0000000000003017","article-title":"Different prognostic implications of 18F-FDG PET between histological subtypes in patients with cervical cancer","volume":"95","author":"Rahman","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.phro.2025.100829_b0110","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijgo.2009.02.009","article-title":"Revised FIGO staging for carcinoma of the cervix","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.phro.2025.100829_b0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137743","article-title":"Comparison of the prognostic value of F-18 PET metabolic parameters of primary tumors and regional lymph nodes in patients with locally advanced cervical cancer who are treated with concurrent chemoradiotherapy","volume":"10","author":"Chong","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.phro.2025.100829_b0120","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20170552","article-title":"Pretreatment metabolic tumour volume and total lesion glycolysis are not independent prognosticators for locally advanced cervical cancer patients treated with chemoradiotherapy","volume":"91","author":"Guler","year":"2018","journal-title":"Br J Radiol"},{"key":"10.1016\/j.phro.2025.100829_b0125","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3390\/diagnostics11040714","article-title":"Pretreatment [18F]FDG PET\/CT prognostic factors in patients with squamous cell cervical carcinoma FIGO IIIC1","volume":"11","author":"Burchardt","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.phro.2025.100829_b0130","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.2214\/AJR.18.19734","article-title":"Prognostic value of volume-based metabolic parameters of 18 F-FDG PET\/CT in uterine cervical cancer: a systematic review and meta-analysis","volume":"211","author":"Han","year":"2018","journal-title":"Am J Roentgenol"}],"container-title":["Physics and Imaging in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631625001344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631625001344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T18:16:47Z","timestamp":1772907407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405631625001344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":26,"alternative-id":["S2405631625001344"],"URL":"https:\/\/doi.org\/10.1016\/j.phro.2025.100829","relation":{},"ISSN":["2405-6316"],"issn-type":[{"value":"2405-6316","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prognostic value of baseline 18FDG \u2013 Positron Emission Tomography \u2013 Computed Tomography in cervical cancer patients treated with definitive chemoradiotherapy \u2013 External multicentre validation model","name":"articletitle","label":"Article Title"},{"value":"Physics and Imaging in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phro.2025.100829","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100829"}}